Adc Therapeutics Sa (ADCT) returns
Adc Therapeutics Sa returns over 5 years
$1,000 invested in Adc Therapeutics Sa five years ago was worth $52.78 at the close on October 30, 2026, with dividends reinvested: an average return of -44.5% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +25.4% | — | $1,254 | -0.9% |
| 3 months | +37.8% | — | $1,378 | +2.1% |
| Year to date | -56.7% | — | $433.43 | +11.7% |
| 1 year | -67.0% | — | $330.45 | +12.4% |
| 3 years | +117.6% | +29.6% | $2,176 | +88.5% |
| 5 years | -94.7% | -44.5% | $52.78 | +76.0% |
Adc Therapeutics Sa return by calendar year
| Year | ADCT | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -56.7% | +11.7% | -68.3% |
| 2025 | +77.4% | +17.7% | +59.7% |
| 2024 | +19.9% | +24.9% | -5.0% |
| 2023 | -56.8% | +26.2% | -83.0% |
| 2022 | -81.0% | -18.2% | -62.8% |
| 2021 | -36.9% | +28.7% | -65.6% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: ADCT financials
No forecast, no recommendation. This page describes Adc Therapeutics Sa from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.